Explore Tesamorelin/Ipamorelin Blend dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator data.
This is a research blend of two growth-hormone peptides, tesamorelin and ipamorelin, paired to study growth-hormone release and body composition. It ships as a lyophilized powder reconstituted before use.
Tesamorelin is a GHRH analog and ipamorelin is a selective growth-hormone secretagogue; they are combined to prompt growth-hormone release through two complementary routes.
Both peptides have their own literature, summarized in their standalone entries, but the specific blend has no published human trial.
Tesamorelin/Ipamorelin Blend has a reported half-life of ~26–38 min (tesamorelin) and ~2 hr (ipamorelin), and the dose intervals researchers model most often fall around once daily (before bed). Both components are short-acting and trigger a GH-releasing pulse rather than a steady level. Neither builds up between doses, so consistent timing matters most. Tesamorelin/Ipamorelin Blend is a blend of Ipamorelin and Tesamorelin, so a reconstitution figure for it covers the combined vial contents rather than any single component. It is catalogued under Other Peptides on WPA.
390 Tesamorelin/Ipamorelin Blend reconstitution calculations have been logged by the WPA community. The most common dose entered is 1mg (134 calculations). The most common bacteriostatic water volume is 2mL. The most popular vial size is 15mg (149 sessions). The most common dosing frequency is 5x/week (60 logged protocols), followed by once weekly (46).
These figures come from anonymized WPA peptide calculator sessions.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.